SELLAS Life Sciences Group, Inc. Human Resources Contracts & Agreements

52 Contracts & Agreements

Browse by Subcategory

Bonus & Incentive Agreements (14 contracts)
Change of Control Agreements (1)
Consulting Agreements (1)
Employment Agreements (32)
Separation Agreements (3)
Severance Agreements (1)

Recent Contracts

Separation Agreement, effective as of March 27, 2024, by and between the Registrant and Barbara Wood (Filed With SEC on March 28, 2024)
Separation Agreement, effective as of March 26, 2024, by and between the Registrant and Robert Francomano (Filed With SEC on March 28, 2024)
Employment Agreement, effective as of February 25, 2022, by and between the Registrant and Robert Francomano (Filed With SEC on March 28, 2024)
2023 Amended and Restated Equity Incentive Plan (Filed With SEC on August 10, 2023)
Severance Agreement, dated March 27, 2023, by and between the Registrant and Robert Francomano (Filed With SEC on May 11, 2023)
Change in Control Severance Agreement, dated December 14, 2021, between SELLAS Life Sciences Group, Inc and Dragan Cicic, M.D (Filed With SEC on December 16, 2021)
Employment Agreement by and between SELLAS Life Sciences Group, Inc. and Angelos Stergiou, effective July 1, 2019 (Filed With SEC on May 14, 2020)
Form of Restricted Stock Unit Grant and Agreement under the 2019 Equity Incentive Plan (Filed With SEC on March 13, 2020)
Form of Stock Option Grant Notice and Option Agreement under the 2019 Equity Incentive Plan (Filed With SEC on March 13, 2020)
2019 Equity Incentive Plan (Filed With SEC on November 14, 2019)
Employment Letter Agreement by and between SELLAS Life Sciences Group Inc. and Gene Mack, effective April 20, 2018 (Filed With SEC on April 20, 2018)
Form of Restricted Stock Unit Grant under the 2017 Equity Incentive Plan (Filed With SEC on April 13, 2018)
Form Nonstatutory Stock Option granted under the Registrants 2016 Incentive Plan (Filed With SEC on April 13, 2018)
Form Incentive Stock Option granted under the Registrants 2016 Incentive Plan (Filed With SEC on April 13, 2018)
Form of Stock Option Grant Notice and Option Agreement under the 2017 Equity Incentive Plan (Filed With SEC on March 19, 2018)
Employment Letter Agreement by and between SELLAS Life Sciences Group Inc. and Barbara Wood, effective March 14, 2018 (Filed With SEC on March 19, 2018)
Employment Agreement by and between SELLAS Life Sciences Group, Inc. and John Burns, dated January 11, 2018 and effective as of December 30, 2017 (Filed With SEC on January 18, 2018)
Consulting Agreement by and between SELLAS Life Sciences Group, Inc. and Thomas J. Knapp (Filed With SEC on January 5, 2018)
2017 Equity Incentive Plan of the Registrant (Filed With SEC on January 5, 2018)
First Amendment to Employment Agreement (Filed With SEC on February 21, 2017)
Galena Biopharma, Inc. 2016 INCENTIVE PLAN EFFECTIVE AS OF JULY 14, 2016 (Filed With SEC on August 22, 2016)
Second Amendment to Employment Agreement (Filed With SEC on August 22, 2016)
SEPARATION AGREEMENT AND RELEASES (Filed With SEC on March 10, 2016)
EMPLOYMENT AGREEMENT (Filed With SEC on November 9, 2015)
Form of Nonstatutory Stock Option Granted Under Galena Biopharma, Inc. 2007 Incentive Plan (Filed With SEC on August 6, 2015)
Form of Incentive Stock Option Granted Under Galena Biopharma 2007 Incentive Plan (Filed With SEC on August 6, 2015)
EMPLOYMENT AGREEMENT (Filed With SEC on November 5, 2014)
EMPLOYMENT AGREEMENT (Filed With SEC on September 18, 2014)
FORM OF EMPLOYMENT AGREEMENT (Filed With SEC on May 6, 2014)
EMPLOYMENT AGREEMENT (Filed With SEC on March 17, 2014)
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on May 9, 2013)
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on March 12, 2013)
EMPLOYMENT AGREEMENT (Filed With SEC on March 12, 2013)
AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT (Filed With SEC on March 12, 2013)
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on September 26, 2011)
EMPLOYMENT AGREEMENT (Filed With SEC on September 26, 2011)
EMPLOYMENT AGREEMENT (Filed With SEC on September 26, 2011)
EMPLOYMENT AGREEMENT (Filed With SEC on April 5, 2011)
EX-10.1 Amendment to Employment Agreement between RXi Pharmaceuticals Corporation and Stephen J. DiPalma, dated May 29, 2009 (Filed With SEC on August 14, 2009)
Ex-10.23 Employment Agreement dated November 10, 2008 (Filed With SEC on March 18, 2009)